Major Medical Partnership Enters Agreement With This Company

LianBio Partners with Bristol Myers Squibb: A Major Leap Forward for Mavacamten in China and Asian Markets.

Today, the world of biotechnology is buzzing with the news that LianBio, a trailblazer in bringing innovative medicines to patients in China and other major Asian markets, has entered into an agreement with global biopharmaceutical giant, Bristol Myers Squibb. This partnership centers around Mavacamten, a groundbreaking drug developed for the treatment …